In the STEP-4 trial (N=803), patients who continued semaglutide 2.4 mg maintained their weight loss, while those who switched to placebo regained an average of 6.9% body weight over 48 weeks, underscoring that this is a chronic therapy rather than a short course
Our guide on grey market peptides explores this landscape in detail, including how to identify reputable suppliers and avoid counterfeit products
Book your BodySpec scan to track your progress
Rduction du stress oxydatif : Agit comme antioxydant, protgeant les cellules des dommages causs par les radicaux libres
Here, you should avoid overexposing your skin to the sun and refrain from smoking
Our exclusion criteria comprised non-original designs, studies investigated on internal GLP-1, studies lacking weight change outcomes, studies without all population undergoing bariatric surgery, absence of baseline patient characteristics